Incidence of Late Failure Following Myeloablative Conditioning with BuCy2 and Matched Sibling Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

被引：0

作者：

Pant, Shubham ^{[1
]}

Hamadani, Sayed Mehdi

Crilley, Pamela ^{[3
]}

Szer, Jeffrey ^{[4
]}

Dodds, Anthony J. ^{[5
]}

Stevenson, Dustin E. ^{[6
]}

Phillips, Gary

Elder, Patrick

Nivison-Smith, Ian ^{[5
]}

Avalos, Belinda ^{[2
]}

Penza, Sam

Topolsky, David ^{[3
]}

Sobecks, R. ^{[7
]}

Kalaycio, Matt ^{[7
]}

Bolwell, Brian J. ^{[7
]}

Copelan, Edward ^{[7
]}

机构：

[1] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA

[2] Ohio State Univ, Div Hematol Oncol, Heart & Lung Res Inst, Columbus, OH 43210 USA

[3] Drexel Univ, Div Hematol Oncol, Coll Med, Philadelphia, PA 19104 USA

[4] Royal Melbourne Hosp, Clin Haematol & BMT Serv, Parkville, Vic 3050, Australia

[5] St Vincents Hosp Sydney Ltd, Sydney, NSW, Australia

[6] Lackland AFB, Lackland AFB, TX USA

[7] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA

来源：

BLOOD | 2008年 / 112卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：757 / 757

页数：1

共 50 条

[1] Incidence and reasons for late failure after allogeneic haematopoietic cell transplantation following BuCy2 in acute myeloid leukaemia
Pant, Shubham
Hamadani, Mehdi
Dodds, Anthony J.
Szer, Jeffrey
Crilley, Pamela A.
Stevenson, Dustin
Phillips, Gary
Elder, Patrick
Nivison-Smith, Ian
Avalos, Belinda R.
Penza, Sam
Topolsky, David
Sobecks, Ronald
Kalaycio, Matt
Bolwell, Brian J.
Copelan, Edward A.
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2010, 148 (04) : 623 - 626
[2] New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2
Sohn, S. K.
Chae, Y. S.
Kim, J. G.
Cho, Y. Y.
Moon, J. H.
Shin, H. J.
Chung, J. S.
Cho, G. J.
Yang, D. H.
Lee, J. J.
Kim, Y. K.
Kim, H. J.
[J]. BONE MARROW TRANSPLANTATION, 2007, 39 : S203 - S204
[3] New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2
Chae, Y. S.
Sohn, S. K.
Kim, J. G.
Cho, Y. Y.
Moon, J. H.
Shin, H. J.
Chung, J. S.
Cho, G. J.
Yang, D. H.
Lee, J-J
Kim, Y-K
Kim, H-J
[J]. BONE MARROW TRANSPLANTATION, 2007, 40 (06) : 541 - 547
[4] New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2
Y S Chae
S K Sohn
J G Kim
Y Y Cho
J H Moon
H J Shin
J S Chung
G J Cho
D H Yang
J-J Lee
Y-K Kim
H-J Kim
[J]. Bone Marrow Transplantation, 2007, 40 : 541 - 547
[5] Fludarabine and busulfan as conditioning regimen in allogeneic stem cell transplantation: comparison with BuCy2
Fedele, R.
Moscato, T.
Massara, E.
Messina, G.
Iacopino, O.
Pontari, A.
Spiniello, E.
Callea, I.
Garreffa, C.
Martino, M.
Console, G.
Gallo, G.
Princi, D.
Monteleone, R.
Irrera, G.
Iacopino, P.
[J]. BONE MARROW TRANSPLANTATION, 2012, 47 : S418 - S419
[6] Reduced Intensity Versus Myeloablative Conditioning for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia
Fan, Donna
Sabry, Waleed
Stakiw, Julie
MacKay, Rebecca Ellyn
Bosch, Mark
Sarker, Sabuj
Elemary, Mohamed
[J]. BLOOD, 2014, 124 (21)
[7] COMPARABLE OUTCOME OF HAPLOIDENTICAL AND MATCHED SIBLING DONOR PERIPHERAL BLOOD STEM CELL TRANSPLANTATION FOLLOWING MYELOABLATIVE CONDITIONING FOR POOR RISK ACUTE MYELOID LEUKEMIA
Jaiswal, S. Rani
Khattry, N.
Punatar, S.
Gupta, A.
Bagal, B.
Chakrabarti, S.
[J]. BONE MARROW TRANSPLANTATION, 2014, 49 : S209 - S209
[8] Comparable Outcomes after Allogeneic Stem-cell Transplantation with Myeloablative BuFlu or BuCy Conditioning Regimens in Acute Myeloid Leukemia - Analysis of the Polish Adult Leukemia Group
Lojko-Dankowska, Anna
Nasilowska-Adamska, Barbara
Mensah-Glanowska, Patrycja
Piekarska, Agnieszka
Matuszak, Magdalena
Piatkowska-Jakubas, Beata
Halaburda, Kazimierz
Wrobel, Tomasz
Komarnicki, Mieczyslaw
Czyz, Anna
[J]. BONE MARROW TRANSPLANTATION, 2018, 53 : 266 - 266
[9] Non-myeloablative conditioning regimen in patients with high risk acute myeloid leukemia:: unrelated and sibling allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Basara, N
Roemer, E
Günzelmann, S
Schmetzer, B
Fauser, AA
Kiehl, MG
[J]. BONE MARROW TRANSPLANTATION, 2001, 27 : S86 - S86
[10] High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid leukemia
Farag, SS
Bolwell, BJ
Elder, PJ
Kalaycio, M
Lin, T
Pohlman, B
Penza, S
Marcucci, G
Blum, W
Sobecks, R
Avalos, BR
Byrd, JC
Copelan, E
[J]. BONE MARROW TRANSPLANTATION, 2005, 35 (07) : 653 - 661

← 1 2 3 4 5 →